Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Lisocabtagene Maraleucel
Generic name : Breyanzi
Manufactured By : BMS
Indications : Relapsed/Refractory Marginal Zone Lymphoma
Medicine Description : A personalized CAR T-cell therapy for relapsed or refractory marginal zone lymphoma, Lisocabtagene Maraleucel (Breyanzi) is an autologous CD19-directed chimeric antigen receptor (CAR) T-cell treatment that reprograms a patient’s own T cells to identify and destroy malignant B cells. It is used in patients whose disease has progressed after multiple prior therapies. Administered as a one-time intravenous infusion, it offers a potentially durable treatment option. Common side effects include cytokine release syndrome, neurological toxicities, infections, and low blood cell counts. Intensive monitoring is required in certified treatment centers to manage treatment-related complications and ensure patient safety.